{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:44:41Z","timestamp":1789764281510,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:00:00Z","timestamp":1516320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["16K19003"],"award-info":[{"award-number":["16K19003"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["24390226"],"award-info":[{"award-number":["24390226"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["25670428"],"award-info":[{"award-number":["25670428"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["25871169"],"award-info":[{"award-number":["25871169"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.omtn.2018.01.007","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T07:37:18Z","timestamp":1517557038000},"page":"79-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Supplemental Treatment for Huntington\u2019s Disease with miR-132 that Is Deficient in Huntington\u2019s Disease Brain"],"prefix":"10.1016","volume":"11","author":[{"given":"Masashi","family":"Fukuoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Chiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Akiko","family":"Popiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohiko","family":"Hohjoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2018.01.007_bib1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2018.01.007_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtn.2018.01.007_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2018.01.007_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.omtn.2018.01.007_bib5","doi-asserted-by":"crossref","first-page":"9740","DOI":"10.1073\/pnas.0403293101","article-title":"An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues","volume":"101","author":"Liu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.01.007_bib6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1261\/rna.7119904","article-title":"Probing microRNAs with microarrays: tissue specificity and functional inference","volume":"10","author":"Babak","year":"2004","journal-title":"RNA"},{"key":"10.1016\/j.omtn.2018.01.007_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bbrc.2007.07.189","article-title":"Marked change in microRNA expression during neuronal differentiation of human teratocarcinoma NTera2D1 and mouse embryonal carcinoma P19 cells","volume":"362","author":"Hohjoh","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2018.01.007_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.gene.2006.11.018","article-title":"Expression profile analysis of microRNA (miRNA) in mouse central nervous system using a new miRNA detection system that examines hybridization signals at every step of washing","volume":"391","author":"Hohjoh","year":"2007","journal-title":"Gene"},{"key":"10.1016\/j.omtn.2018.01.007_bib9","doi-asserted-by":"crossref","first-page":"e3420","DOI":"10.1371\/journal.pone.0003420","article-title":"An analysis of human microRNA and disease associations","volume":"3","author":"Lu","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2018.01.007_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/nat.2012.0356","article-title":"Developing microRNA therapeutics: approaching the unique complexities","volume":"22","author":"Jackson","year":"2012","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2018.01.007_bib11","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/sj.mt.6300311","article-title":"MicroRNAs in disease and potential therapeutic applications","volume":"15","author":"Soifer","year":"2007","journal-title":"Mol Ther."},{"key":"10.1016\/j.omtn.2018.01.007_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.gene.2011.05.034","article-title":"Alteration of microRNA expression in the process of mouse brain growth","volume":"485","author":"Eda","year":"2011","journal-title":"Gene"},{"key":"10.1016\/j.omtn.2018.01.007_bib13","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1093\/nar\/gks151","article-title":"miR-212\/132 expression and functions: within and beyond the neuronal compartment","volume":"40","author":"Wanet","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2018.01.007_bib14","doi-asserted-by":"crossref","first-page":"20382","DOI":"10.1073\/pnas.1015691107","article-title":"microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus","volume":"107","author":"Magill","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.01.007_bib15","doi-asserted-by":"crossref","first-page":"e62509","DOI":"10.1371\/journal.pone.0062509","article-title":"miR-132\/212 knockout mice reveal roles for these miRNAs in regulating cortical synaptic transmission and plasticity","volume":"8","author":"Remenyi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2018.01.007_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/BJ20100024","article-title":"Regulation of the miR-212\/132 locus by MSK1 and CREB in response to neurotrophins","volume":"428","author":"Remenyi","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.omtn.2018.01.007_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","article-title":"Altered microRNA regulation in Huntington\u2019s disease models","volume":"227","author":"Lee","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtn.2018.01.007_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","article-title":"A microRNA-based gene dysregulation pathway in Huntington\u2019s disease","volume":"29","author":"Johnson","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtn.2018.01.007_bib19","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nn2010","article-title":"Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA","volume":"10","author":"Klein","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtn.2018.01.007_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mcn.2009.10.005","article-title":"An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling","volume":"43","author":"Impey","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.omtn.2018.01.007_bib21","doi-asserted-by":"crossref","first-page":"16426","DOI":"10.1073\/pnas.0508448102","article-title":"A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis","volume":"102","author":"Vo","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.01.007_bib22","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1073\/pnas.0803072105","article-title":"An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP","volume":"105","author":"Wayman","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.01.007_bib23","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1093\/hmg\/ddr330","article-title":"MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy","volume":"20","author":"Smith","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2018.01.007_bib24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neuron.2007.05.017","article-title":"microRNA modulation of circadian-clock period and entrainment","volume":"54","author":"Cheng","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2018.01.007_bib25","doi-asserted-by":"crossref","first-page":"15488","DOI":"10.1038\/ncomms15488","article-title":"Mir-132\/212 is required for maturation of binocular matching of orientation preference and depth perception","volume":"8","author":"Mazziotti","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2018.01.007_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2018.01.007_bib27","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2018.01.007_bib28","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1093\/hmg\/ddg295","article-title":"Pathogenesis of polyglutamine disorders: aggregation revisited","volume":"12","author":"Michalik","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2018.01.007_bib29","doi-asserted-by":"crossref","first-page":"21731","DOI":"10.1073\/pnas.1012153107","article-title":"Tailor-made RNAi knockdown against triplet repeat disease-causing alleles","volume":"107","author":"Takahashi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.01.007_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2009.03.004","article-title":"A majority of Huntington\u2019s disease patients may be treatable by individualized allele-specific RNA interference","volume":"217","author":"Lombardi","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtn.2018.01.007_bib31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five\u00a0siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington\u2019s disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.omtn.2018.01.007_bib32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/ph6040522","article-title":"Disease-causing allele-specific silencing by RNA interference","volume":"6","author":"Hohjoh","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.omtn.2018.01.007_bib33","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1038\/ncomms11758","article-title":"Human glia can both induce and rescue aspects of disease phenotype in Huntington disease","volume":"7","author":"Benraiss","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2018.01.007_bib34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nbt.3514","article-title":"Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases","volume":"34","author":"Chen","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2018.01.007_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-122350","article-title":"A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer\u2019s disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls","volume":"35","author":"H\u00e9bert","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.omtn.2018.01.007_bib36","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/emmm.201201974","article-title":"Alteration of the microRNA network during the progression of Alzheimer\u2019s disease","volume":"5","author":"Lau","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtn.2018.01.007_bib37","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/hmg\/ddt164","article-title":"De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer\u2019s disease","volume":"22","author":"Wong","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2018.01.007_bib38","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1073\/pnas.1113793109","article-title":"MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function","volume":"109","author":"Miller","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.01.007_bib39","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/hmg\/ddt499","article-title":"MeCP2: a novel Huntingtin interactor","volume":"23","author":"McFarland","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2018.01.007_bib40","doi-asserted-by":"crossref","first-page":"e51069","DOI":"10.1371\/journal.pone.0051069","article-title":"Hsp40 gene therapy exerts therapeutic effects on polyglutamine disease mice via a non-cell autonomous mechanism","volume":"7","author":"Popiel","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2018.01.007_bib41","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/hum.2009.006","article-title":"Scalable purification of adeno-associated virus serotype 1 (AAV1) and AAV8 vectors, using dual ion-exchange adsorptive membranes","volume":"20","author":"Okada","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2018.01.007_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2183\/pjab.79B.293","article-title":"Specific inhibition of Huntington\u2019s disease gene expression by siRNAs in cultured cells","volume":"79B","author":"Liu","year":"2003","journal-title":"P Jpn Acad B-Phys."},{"key":"10.1016\/j.omtn.2018.01.007_bib43","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1091\/mbc.e02-09-0623","article-title":"p250GAP, a novel brain-enriched GTPase-activating protein for Rho family GTPases, is involved in the N-methyl-d-aspartate receptor signaling","volume":"14","author":"Nakazawa","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.omtn.2018.01.007_bib44","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1471-4159.2008.05335.x","article-title":"Regulation of dendritic spine morphology by an NMDA receptor-associated Rho GTPase-activating protein, p250GAP","volume":"105","author":"Nakazawa","year":"2008","journal-title":"J.\u00a0Neurochem."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118300088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118300088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:11:41Z","timestamp":1772226701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253118300088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":44,"alternative-id":["S2162253118300088"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2018.01.007","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supplemental Treatment for Huntington\u2019s Disease with miR-132 that Is Deficient in Huntington\u2019s Disease Brain","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2018.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}